Company profile

BioCardia, Inc. insider acquisitions

Company CIK 0000925741 · Reported insider acquisitions and filing context.

Company filings at SEC ↗
BCDA · Nasdaq

These are company listings. A transaction is linked to a particular security only when the filing provides enough information.

Company activity summary

By transaction date, as of October 24, 2026.

7 days30 days90 daysOverlapping periods · securities and currencies kept separate

No records are loaded for this 7-day transaction window. This does not establish that no transactions occurred.

Known purchase value sums available amounts for non-derivative purchases only. Missing amounts are excluded. “Currency not specified” does not establish that the amounts share a currency. These summaries use all matching loaded records, while the timeline below covers only the current page.

Transaction timeline

Who reported an acquisition, and when the transaction occurred.

Reported acquisitions by transaction dateEach row is a reporting owner. Select a marker to open its transaction details. Jointly reported transactions appear for each associated reporting owner, without dividing quantities or amounts.Altman PeterAltman PeterMcClung DavidMcClung DavidGILLIS EDWARD MGILLIS EDWARD MAllen Jim L.Allen Jim L.MOYES JAY MMOYES JAY MFacteau BillFacteau BillSTERTZER SIMON HSTERTZER SIMON HBlank Andrew ScottBlank Andrew ScottAltman Peter · October 16, 2026 · Purchase · Common StockAltman Peter · October 15, 2026 · Purchase · Common StockAltman Peter · December 17, 2025 · Purchase · Common StockAltman Peter · December 16, 2025 · Purchase · Common StockAltman Peter · December 8, 2025 · Stock award · Stock Option (right to buy)Altman Peter · December 8, 2025 · Other acquisition · Common StockAltman Peter · December 8, 2025 · Stock award · Common StockMcClung David · December 8, 2025 · Stock award · Stock Option (right to buy)McClung David · December 8, 2025 · Other acquisition · Common StockMcClung David · December 8, 2025 · Stock award · Common StockGILLIS EDWARD M · December 8, 2025 · Stock award · Stock Option (right to buy)GILLIS EDWARD M · December 8, 2025 · Other acquisition · Common StockGILLIS EDWARD M · December 8, 2025 · Stock award · Common StockAllen Jim L. · December 8, 2025 · Stock award · Stock Option (right to buy)MOYES JAY M · December 8, 2025 · Stock award · Stock Option (right to buy)Facteau Bill · December 8, 2025 · Stock award · Stock Option (right to buy)STERTZER SIMON H · December 8, 2025 · Stock award · Stock Option (right to buy)Blank Andrew Scott · December 8, 2025 · Stock award · Stock Option (right to buy)Dec 8, 2025Oct 16, 2026
PurchaseStock awardGift receivedExercise / conversionConversionOther acquisition

19 dated transactions · 8 of 9 reporting owners shown. Select one owner to focus the chart.

View timeline as a table
Transaction dateCompany / securityReporting ownersAcquisition type
Oct 16, 2026BioCardia, Inc.Common StockAltman PeterPurchase
Oct 15, 2026BioCardia, Inc.Common StockAltman PeterPurchase
Dec 17, 2025BioCardia, Inc.Common StockAltman PeterPurchase
Dec 16, 2025BioCardia, Inc.Common StockAltman PeterPurchase
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)Altman PeterStock award
Dec 8, 2025BioCardia, Inc.Common StockAltman PeterOther acquisition
Dec 8, 2025BioCardia, Inc.Common StockAltman PeterStock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)McClung DavidStock award
Dec 8, 2025BioCardia, Inc.Common StockMcClung DavidOther acquisition
Dec 8, 2025BioCardia, Inc.Common StockMcClung DavidStock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)GILLIS EDWARD MStock award
Dec 8, 2025BioCardia, Inc.Common StockGILLIS EDWARD MOther acquisition
Dec 8, 2025BioCardia, Inc.Common StockGILLIS EDWARD MStock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)Allen Jim L.Stock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)MOYES JAY MStock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)Facteau BillStock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)STERTZER SIMON HStock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)Blank Andrew ScottStock award
Dec 8, 2025BioCardia, Inc.Stock Option (right to buy)Slosman MarvinStock award

Only transactions on this page are shown. Date windows end on the latest transaction date in this sample. Joint filings may appear on more than one row. Sales are not included. Share-price charts use a separate data source.

Share price & reported acquisitions

Daily closing prices from a separate source. The date window above also filters prices; reporting-owner and transaction-type selections filter the markers.

Price history is not available

Market-price history is not connected yet.

BCDA · Currency not specified. A marker uses that day's closing price, not the reported transaction price. No price is substituted for a missing trading day.

Reported acquisitions

Filing-date filters apply to the list and timeline. The summary above uses transaction dates.

Reset
Reported insider acquisitions, ordered by filing date, newest first. Currency is shown only when reported.
Filed / transactedReporting ownersType / securityQuantityPrice / reference valueDetails
Trade:
Altman PeterPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P3000.95 *Value: 285Currency not specifiedView ↗
Trade:
Altman PeterPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P2000.95 *Value: 190Currency not specifiedView ↗
Trade:
Altman PeterPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P9001.3 *Value: 1,170Currency not specifiedView ↗
Trade:
Altman PeterPresident and CEO · Director
PurchaseCommon StockNon-derivative security · Code P2001.37 *Value: 274Currency not specifiedView ↗
Trade:
Altman PeterPresident and CEO · Director
Stock awardStock Option (right to buy)Derivative security · Code A38,0000Value: 0Currency not specifiedView ↗
Trade:
Altman PeterPresident and CEO · Director
Other acquisitionCommon StockNon-derivative security · Code F56,4841.37 *Value: 77,383.08Currency not specifiedView ↗
Trade:
Altman PeterPresident and CEO · Director
Stock awardCommon StockNon-derivative security · Code A106,5881.37 *Value: 146,025.56Currency not specifiedView ↗
Trade:
McClung DavidChief Financial Officer
Stock awardStock Option (right to buy)Derivative security · Code A27,0000Value: 0Currency not specifiedView ↗
Trade:
McClung DavidChief Financial Officer
Other acquisitionCommon StockNon-derivative security · Code F29,3391.37 *Value: 40,194.43Currency not specifiedView ↗
Trade:
McClung DavidChief Financial Officer
Stock awardCommon StockNon-derivative security · Code A58,2761.37 *Value: 79,838.12Currency not specifiedView ↗
Trade:
GILLIS EDWARD MSenior Vice President, Devices
Stock awardStock Option (right to buy)Derivative security · Code A20,0000Value: 0Currency not specifiedView ↗
Trade:
GILLIS EDWARD MSenior Vice President, Devices
Other acquisitionCommon StockNon-derivative security · Code F15,1721.37 *Value: 20,785.64Currency not specifiedView ↗
Trade:
GILLIS EDWARD MSenior Vice President, Devices
Stock awardCommon StockNon-derivative security · Code A38,0781.37 *Value: 52,166.86Currency not specifiedView ↗
Trade:
Allen Jim L.Director
Stock awardStock Option (right to buy)Derivative security · Code A12,0000Value: 0Currency not specifiedView ↗
Trade:
MOYES JAY MDirector
Stock awardStock Option (right to buy)Derivative security · Code A12,0000Value: 0Currency not specifiedView ↗
Trade:
Facteau BillDirector
Stock awardStock Option (right to buy)Derivative security · Code A12,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A12,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A12,0000Value: 0Currency not specifiedView ↗
Trade: Stock awardStock Option (right to buy)Derivative security · Code A12,0000Value: 0Currency not specifiedView ↗

Reporting owners are associated with a filing. Jointly reported amounts are not allocated to individual owners. Historical coverage is still being built. Read the methodology →